{"uniprot":"Q8WW27","gene":"APOBEC4","name":"Putative C->U-editing enzyme APOBEC-4","organism":"Homo sapiens (Human)","status":"dark","length":367,"sequence":"MEPIYEEYLANHGTIVKPYYWLSFSLDCSNCPYHIRTGEEARVSLTEFCQIFGFPYGTTFPQTKHLTFYELKTSSGSLVQKGHASSCTGNYIHPESMLFEMNGYLDSAIYNNDSIRHIILYSNNSPCNEANHCCISKMYNFLITYPGITLSIYFSQLYHTEMDFPASAWNREALRSLASLWPRVVLSPISGGIWHSVLHSFISGVSGSHVFQPILTGRALADRHNAYEINAITGVKPYFTDVLLQTKRNPNTKAQEALESYPLNNAFPGQFFQMPSGQLQPNLPPDLRAPVVFVLVPLRDLPPMHMGQNPNKPRNIVRHLNMPQMSFQETKDLGRLPTGRSVEIVEITEQFASSKEADEKKKKKGKK","function_summary":"A soluble human RNA–RNP assembly factor that uses a deaminase-derived scaffold to organize RNA-editing and surveillance complexes. By forming stable multivalent interfaces, it promotes cytidine-to-uridine editing and broader mRNA modification while attenuating decay pathways linked to nonsense-mediated decay. Operating between nucleoplasm and cytoplasm, it coordinates transcript fate and indirectly tunes lipid-metabolism programs through regulation of RNA processing and stability.","plain_language":"APOBEC4 has barely been studied. The model's best guess: A soluble human RNA–RNP assembly factor that uses a deaminase-derived scaffold to organize RNA-editing and surveillance complexes. By forming stable multivalent interfaces, it promotes cytidine-to-uridine editing and broader mRNA modification while attenuating decay pathways linked to nonsense-mediated decay.","uniprot_summary":"Involved in RNA editing.","go_terms":{"molecular_function":[{"id":"GO:0005515","label":"protein binding"}],"biological_process":[{"id":"GO:0006629","label":"lipid metabolic process"},{"id":"GO:2000622","label":"regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay"},{"id":"GO:0016556","label":"mRNA modification"},{"id":"GO:0016554","label":"cytidine to uridine editing"}],"cellular_component":[{"id":"GO:0005737","label":"cytoplasm"},{"id":"GO:0005654","label":"nucleoplasm"}]},"interpro":[{"id":"IPR059203","name":"APOBEC4, cytosine deaminase domain","type":"domain","start":1,"end":236},{"id":"IPR002125","name":"Cytidine and deoxycytidylate deaminase domain","type":"domain","start":61,"end":177},{"id":"IPR038953","name":"Putative deaminase APOBEC-4","type":"family","start":1,"end":367}],"reasoning":"I begin with the InterPro architecture. The N-terminal two-thirds of the polypeptide (residues 1–236) is covered by IPR059203 (APOBEC4, cytosine deaminase domain), and within this region sits IPR002125 (Cytidine and deoxycytidylate deaminase domain, residues 61–177). This layered arrangement indicates a catalytic core derived from cytidine/deoxycytidylate deaminases that typically hydrolyze cytosine or cytidine via a metal-activated active site. The full-length sequence is encompassed by IPR038953 (Putative deaminase APOBEC-4 family, residues 1–367), which frames the protein as a member of an APOBEC-like clade whose chemistry is often repurposed for RNA-directed editing. The ordered layout—an N-terminal deaminase fold with internal confirmation by a canonical cytidine deaminase signature—causally supports nucleic-acid-associated chemistry and scaffolding, while the absence of additional catalytic modules suggests that regulation and assembly via protein–protein contacts is prominent.\n\nFrom this domain logic, the primary molecular function is mediated assembly rather than high-flux catalysis. The deaminase fold frequently doubles as a rigid scaffold for nucleic-acid recognition and partner recruitment. This architecture naturally produces multivalent interfaces that stabilize ribonucleoprotein complexes, aligning with GO:0005515 protein binding as the operative molecular function. The fold’s chemistry-agnostic surfaces and conserved grooves explain how the protein binds partners and RNA-modifying assemblies.\n\nThese binding-driven assemblies drive several connected biological processes. First, the deaminase-derived scaffold enables cytidine-to-uridine editing on RNA, matching GO:0016554 cytidine to uridine editing. By organizing RNA-editing and RNP-modifying machinery, the protein directly contributes to GO:0016556 mRNA modification. Second, the same assemblies can shield transcripts from surveillance pathways, explaining GO:2000622 regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay: by sequestering or remodeling RNPs, the complex can attenuate NMD signaling. Third, the APOBEC-like lineage and lipid-metabolism connections rationalize GO:0006629 lipid metabolic process—either through direct modulation of lipid-handling enzymes or by controlling the stability and translation of lipid-metabolism transcripts.\n\nCellular localization follows from the need to coordinate RNA processing and surveillance. The soluble, scaffold-like architecture and absence of transmembrane features place the protein in soluble compartments. Its role in transcript handling and editing requires access to chromatin-proximal and cytoplasmic RNPs, supporting GO:0005654 nucleoplasm and GO:0005737 cytoplasm. Shuttling between nucleoplasm and cytoplasm allows it to couple nuclear RNA maturation with cytoplasmic fate decisions.\n\nMechanistically, I hypothesize that the deaminase domain forms a rigid platform that recruits RNA-editing and decay-modulating factors. In the nucleoplasm, it assembles with RNA-processing modules to imprint transcripts with editing marks; in the cytoplasm, it buffers RNPs against surveillance, dampening nonsense-mediated decay. Likely partners include APOBEC-family adaptors and RNA-editing cofactors that together tune editing efficiency and decay resistance. Through these assemblies, the protein coordinates mRNA modification and lipid-metabolic gene expression programs, using protein-binding surfaces derived from its cytidine deaminase fold to choreograph RNA fate across nuclear and cytoplasmic compartments.","category":"dark","control_evaluation":null,"validation_plan":null,"structure":{"source":"AlphaFold DB","pdb":"/structures/AF-Q8WW27.pdb","alphafold":"https://alphafold.ebi.ac.uk/entry/Q8WW27"},"links":{"uniprot":"https://www.uniprot.org/uniprotkb/Q8WW27/entry","atlas":"/p/Q8WW27"},"provenance":{"model":"BioReason-Pro (ESM3 esm3-sm-open-v1)","source_list":"Pharos Tdark","note":"AI prediction, not experimentally verified"}}